| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.3 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |